Catalyst Pharmaceutical Inc. (NASDAQ: CPRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CATALYST PHARMACEUTICAL INC.

Catalyst Pharmaceutical Inc. (NASDAQ: CPRX)
Listen to this Section


$31.29
-0.0050 ( -0.02% ) 691.6K

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Market Data


Open $31.29
Previous Close $31.29
Volume 691.6K
Market Cap $3.83B
Day Range $31.26 - $31.30
52 Week Range $19.05 - $32.56
Shares Outstanding 122.38M
Change % -0.02%
Net Change ▼ -0.0050
Insider Ownership -0.27%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2006
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -298,932.00

Date Type Amount Purchased Purchaser
2024-08-13 Sale -100000.00 INGENITO GARY
2024-08-13 Sale -6058.00 Del Carmen Jeffrey
2024-06-11 Sale -7541.00 Del Carmen Jeffrey
2024-06-07 Sale -80000.00 INGENITO GARY
2024-06-05 Sale -5333.00 Harper Molly
2024-06-05 Sale -40000.00 Daly Richard J
2023-08-04 Sale -60000.00 DENKHAUS DONALD A

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Aug 08, 2025
8-k 8K-related 13 Aug 07, 2025
10-q Quarterly Reports 92 Aug 06, 2025
8-k 8K-related 13 Aug 06, 2025
8-k 8K-related 13 Aug 04, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 10, 2025
3 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 03, 2025
8-k 8K-related 13 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy